Epzicom - 49349-701-19 - (Abacavir Sulfate and Lamivudine)

Alphabetical Index


Drug Information of Epzicom

Product NDC: 49349-701
Proprietary Name: Epzicom
Non Proprietary Name: Abacavir Sulfate and Lamivudine
Active Ingredient(s): 600; 300    mg/1; mg/1 & nbsp;   Abacavir Sulfate and Lamivudine
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Epzicom

Product NDC: 49349-701
Labeler Name: REMEDYREPACK INC.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021652
Marketing Category: NDA
Start Marketing Date: 20110912

Package Information of Epzicom

Package NDC: 49349-701-19
Package Description: 90 TABLET, FILM COATED in 1 CANISTER (49349-701-19)

NDC Information of Epzicom

NDC Code 49349-701-19
Proprietary Name Epzicom
Package Description 90 TABLET, FILM COATED in 1 CANISTER (49349-701-19)
Product NDC 49349-701
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Abacavir Sulfate and Lamivudine
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20110912
Marketing Category Name NDA
Labeler Name REMEDYREPACK INC.
Substance Name ABACAVIR SULFATE; LAMIVUDINE
Strength Number 600; 300
Strength Unit mg/1; mg/1
Pharmaceutical Classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of Epzicom


General Information